HCV Coinfection Slows Disease Progression in HIV-Infected Plasma Donors
Author Information
Author(s): Zhang Xiaoyan, Xu Jianqing, Peng Hong, Ma Yan, Han Lifeng, Ruan Yuhua, Su Bing, Wang Ning, Shao Yiming
Primary Institution: State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, China CDC
Hypothesis
How does HCV coinfection influence the disease progression during HIV-1 infection?
Conclusion
HCV coinfection with HIV-1 is associated with slower disease progression compared to HIV-1 mono-infection.
Supporting Evidence
- 35% of HIV-1 mono-infected subjects maintained CD4+ T-cell counts above 200 cells/µl compared to 56% in the HIV/HCV group.
- HIV viral loads were consistently higher in the HIV mono-infection group than in the HIV/HCV group.
- CD4+ T-cell counts were significantly higher in the HIV/HCV group at multiple follow-up visits.
Takeaway
Having both HIV and HCV might actually help people with HIV stay healthier for longer compared to just having HIV alone.
Methodology
A cohort study was conducted with 168 HIV-1-infected former plasma donors monitored over 33 months, measuring CD4+ T-cell counts and HIV-1 viral loads.
Potential Biases
Potential biases may arise from the specific demographic and epidemiological characteristics of the cohort.
Limitations
The study is limited to a specific population of former plasma donors in China, which may not be generalizable to all HIV-infected individuals.
Participant Demographics
The cohort consisted of 56.9% male and 43.1% female participants, with an average age of 44.27 years.
Statistical Information
P-Value
p=0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website